ArticleTranslational pediatrics2025
The role of fecal short-chain fatty acids in neonatal necrotizing enterocolitis.
Article in Translational pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Maternal and perinatal risk factors for necrotizing enterocolitis.World journal of pediatric surgery · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The metabolites of microbiota may contribute to the pathogenesis of neonatal necrotizing enterocolitis (NEC). The aim of this study was to explore the role of fecal short-chain fatty acids (SCFAs) in the development and progression of NEC. Methods: This study was a retrospective case-control study. The included infants with NEC and non-NEC infants who were hospitalized during the same period were classified into the NEC and control groups, respectively. The concentrations of SCFAs were measured by chromatography-mass spectrometry analysis. The clinical data and concentrations of SCFAs were compared between the NEC and control groups. The association between clinical data, concentrations of SCFAs, and levels of C-reactive protein (CRP) and procalcitonin (PCT) was assessed by Spearman correlation analysis and multivariate linear regression analysis. The predictive values of factors with statistical significance were assessed by receiver operator characteristic curve. Results: Twenty-one infants with NEC and 27 non-NEC infants were included in our study. Propionic acid and butyric acid were positively correlated with the incidence of NEC, while isobutyric acid, valeric acid, isocaproic acid, and caproic acid were negatively correlated with the incidence of NEC. Propionic acid concentrations were positively correlated with levels of CRP and PCT. Birth weight, gestational age, isobutyric acid, isocaproic acid, caproic acid, and valeric acid concentrations were negatively correlated with the levels of PCT. Increased propionate acid concentration and decreased butyric acid concentration were risk factors for increased PCT. The decreased level of valeric acid was an independent risk factor for the occurrence of NEC. Conclusions: Certain SCFAs were associated with the development and progression of NEC.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.